Colonic diverticulitis in chemotherapy patients: Should operative indications change? A retrospective cohort study

International Journal of Surgery

Volumn 12, Issue 12, 2014, Pages 1489-1494

  Samdani, Tushar ^a   Pieracci, Fredric M ^b   Eachempati, Soumitra R ^b   Benarroch Gampel, Jaime ^a   Weiss, Alex ^a   Pietanza, M Cathy ^a   Barie, Philip S ^b   Nash, Garrett M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Colon cancer; Immunosuppression; Interval resection; Morbidity; Recurrence

Indexed keywords

ANTINEOPLASTIC AGENT; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; PACLITAXEL; PLATINUM; VINCA ALKALOID;

ABDOMINAL ABSCESS; ABDOMINAL BLEEDING; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURGERY; COHORT ANALYSIS; COLON CANCER; COLON DIVERTICULOSIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYSTOCOLIC FISTULA; DISEASE SEVERITY; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HUMAN; ILEUS; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIMODALITY CANCER THERAPY; PATIENT DECISION MAKING; PNEUMONIA; RECURRENT DISEASE; RETROSPECTIVE STUDY; SEPSIS; SURGICAL INFECTION; SURGICAL MORTALITY; URINARY TRACT INFECTION; VENOUS THROMBOEMBOLISM; WOUND DEHISCENCE; ACUTE DISEASE; COLONIC NEOPLASMS; COMPLICATION; DIVERTICULITIS, COLONIC; ELECTIVE SURGERY; IMMUNOCOMPROMIZED PATIENT; IMMUNOLOGY; MIDDLE AGED; VERY ELDERLY;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COHORT STUDIES; COLONIC NEOPLASMS; DIVERTICULITIS, COLONIC; ELECTIVE SURGICAL PROCEDURES; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 84918800754     PISSN: 17439191     EISSN: 17439159     Source Type: Journal    
DOI: 10.1016/j.ijsu.2014.10.032     Document Type: Article

References (28)

1. Blachut K., Paradowski L., Garcarek J. Prevalence and distribution of the colonic diverticulosis. Review of 417 cases from lower Silesia in Poland. Rom. J. Gastroenterol. 2004, 13(4):281-285.
2. Loffeld R.J., Van Der Putten A.B. Diverticular disease of the colon and concomitant abnormalities in patients undergoing endoscopic evaluation of the large bowel. Colorectal Dis. 2002, 4(3):189-192.
3. Paspatis G.A., Papanikolaou N., Zois E., Michalodimitrakis E. Prevalence of polyps and diverticulosis of the large bowel in the Cretan population. An autopsy study. Int. J. Colorectal Dis. 2001, 16(4):257-261.
4. Rafferty J., Shellito P., Hyman N.H., Buie W.D. Standards committee of American society of colon and rectal surgeons. Practice parameters for sigmoid diverticulitis. Dis. Colon Rectum 2006, 49(7):939-944.
5. Gaertner W.B., Kwaan M., Madoff R.D., et al. The evolving role of laparoscopy in colonic diverticular disease: a systematic review. World J. Surg. 2013, 37(3):629-638.
6. Tursi A. Advances in the management of colonic diverticulitis. Can. Med. Assoc. J. 2012, 184(13):1470-1476.
7. Janes S., Meagher A., Frizelle F.A. Elective surgery after acute diverticulitis. Br. J. Surg. 2005, 92(2):133-142.
8. Parks T.G. Natural history of diverticular disease of the colon. A review of 521 cases. Br. Med. J. 1969, 4(5684):639-642.
9. Pieracci F.M., Barie P.S. Management of severe sepsis of abdominal origin. Scand. J. Surg. 2007, 96(3):184-196.
10. Morris C.R., Harvey I.M., Stebbings W.S., Hart A.R. Incidence of perforated diverticulitis and risk factors for death in a UK population. Br. J. Surg. 2008, 95(7):876-881.
11. Boles R.S., Jordan S.M. The clinical significance of diverticulosis. Gastroenterology 1958, 35(6):579-582.
12. Broderick-Villa G., Burchette R.J., Collins J.C., Abbas M.A., Haigh P.I. Hospitalization for acute diverticulitis does not mandate routine elective colectomy. Arch. Surg. 2005, 140(6):576-581. discussion 581-3.
13. Chappuis C.W., Cohn I. Acute colonic diverticulitis. Surg. Clin. North Am. 1988, 68(2):301-313.
14. Anaya D., Flum D. Assessing the risk of emergency colectomy and colostomy in patients with diverticular disease. Presented at the American College of Surgeons 90th Annual Clinical Congress, New Orleans, LA October 2004.
15. Tursi A., Elisei W., Giorgetti G.M., Inchingolo C.D., Nenna R., Picchio M., Brandimarte G. Detection of endoscopic and histologic inflammation after an attack of colonic diverticulitis is associated with higher diverticulitis recurrence. J.Gastrointest. Liver Dis. 2013, 22(1):13-19.
16. Biondo S., Borao J.L., Kreisler E., et al. Recurrence and virulence of colonic diverticulitis in immunocompromised patients. Am. J. Surg. 2012, 204(2):172-179.
17. Chapman J., Davies M., Wolff B., et al. Complicated diverticulitis: is it time to rethink the rules?. Ann. Surg. 2005, 242(4):576-581. discussion 581-3.
18. Salem L., Veenstra D.L., Sullivan S.D., Flum D.R. The timing of elective colectomy in diverticulitis: a decision analysis. J.Am. Coll. Surg. 2004, 199(6):904-912.
19. Perkins J.D., Shield C.F., Chang F.C., Farha G.J. Acute diverticulitis. Comparison of treatment in immunocompromised and nonimmunocompromised patients. Am. J. Surg. 1984, 148(6):745-748.
20. Tyau E.S., Prystowsky J.B., Joehl R.J., Nahrwold D.L. Acute diverticulitis. A complicated problem in the immunocompromised patient. Arch. Surg. 1991, 126(7):855-858. discussion 858-9.
21. Farthmann E.H., Ruckauer K.D., Haring R.U. Evidence-based surgery: diverticulitis-a surgical disease?. Langenbecks Arch. Surg. 2000, 385(2):143-151.
22. Feingold D., Steele S.R., Lee S., et al. Practice parameters for the treatment of sigmoid diverticulitis-supporting documentation. The standards task force. The American Society of Colon and Rectal Surgeons. Dis. Colon Rectum 2014, 57:284-294.
23. Martin S.T., Stocchi L. New and emerging treatments for the prevention of recurrent diverticulitis. Clin. Exp. Gastroenterol. 2011, 4:203-212.
24. Sachar D.B. Diverticulitis in immunosuppressed patients. J.Clin. Gastroenterol. 2008, 42(10):1154-1155. National Diverticulitis Study Group.
25. Steele T.A. Chemotherapy-induced immunosuppression and reconstitution of immune function. Leuk. Res. 2002, 26(4):411-414.
26. Rasmussen L., Arvin A. Chemotherapy-induced immunosuppression. Environ. Health Perspect. 1982, 43:21-25.
27. Gutierrez M.G., Kirkpatrick C.H. Recognition of the immunocompromised patient. Chest Surg. Clin. N. Am. 1999, 9(1):1-18.
28. Grobmyer S.R., Pieracci F.M., Allen P.J., Brennan M.F., Jaques D.P. Defining morbidity after pancreaticoduodenectomy: use of a prospective complication grading system. J.Am. Coll. Surg. 2007, 204(3):356-364.